Huya Bioscience International, LLC

Vical Incorporated

Huyabio International, LLC

Alain Rolland

Mireille Gillings

Reid P Bissonnette

Jukka Hartikka

Joel D Enas

Sean M Sullivan

Provided herein are combinations that include an HDACi and a PD-1 inhibitor that are useful for treating cancer, including reducing and/or preventing cancer metastasis. The combination is also useful for treating cancer that has been previously treated with a PD-L1 inhibitor.

Combination therapies of HDAC inhibitors and PD-1 inhibitors

Provided herein are combinations that include an HDACi and a PD-L1 inhibitor that are useful for treating cancer, including cancer resistant to PD-1 inhibitors.

Combination therapies of HDAC inhibitors and PD-L1 inhibitors

The disclosure provides adjuvants, immunogenic compositions, and methods useful for vaccination and immune response. In particular, the disclosure provides a class of adjuvants comprising cationic lipid:co-lipid mixtures and methods for delivering formulated compositions.

Compositions and methods for enhancing immune responses to vaccines

Growing community of inventors

San Diego, CA, United States of America

Alain Rolland